Mesoporous silica compositions for modulating immune responses
US9937249B2 · kind B2 · utility
15Cited by
45References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2013 |
| Grant date | Apr 10, 2018 |
| Priority date | — |
| Expiry date | Apr 16, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition comprising mesoporous silica rods comprising an immune cell recruitment compound and an immune cell activation compound, and optionally comprising an antigen such as a tumor lysate. The composition is used to elicit an immune response to a vaccine antigen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.